发明名称 Inhibitors of Viral Replication, Their Process of Preparation and Their Therapeutical Uses
摘要 The present invention relates to compounds of formula (I), their the treatment or the prevention of viral disorders, including HIV.;
申请公布号 US2015274673(A1) 申请公布日期 2015.10.01
申请号 US201314432671 申请日期 2013.10.07
申请人 LABORATOIRE BIODIM 发明人 Benarous Richard;Chevreuil Francis;Ledoussal Benoit;Chasset Sophie;Le Strat Frédéric
分类号 C07D231/12;A61K31/415;C07D405/04;A61K31/4155;C07D401/04;C07D409/04;C07D417/14;A61K31/427;C07D405/14;A61K31/4439;A61K45/06;C07D409/14 主分类号 C07D231/12
代理机构 代理人
主权项 1. A compound of formula (I): wherein R1 represents —CF3; a linear or branched C1-C6 alkyl; a linear or branched C2-C6 alkenyl; a linear or branched C2-C6 alkynyl; a linear or branched fluoroalkyl; a C3-C6 cycloalkyl, CH2OH or —CH2—O—CH3;R2, non-substituted or substituted by at least one T′, represents a linear or branched C2-C8 alkyl; a linear or branched C2-C8 alkenyl; a linear or branched C2-C8 alkynyl; a linear or branched C1-C8 heteroalkyl; a linear or branched C2-C8 heteroalkenyl; a linear or branched C2-C8 heteroalkynyl; a saturated, partially or totally unsaturated or aromatic 3-, 4-, 5-, 6- or 7-membered carbocycle; a saturated, partially or totally unsaturated or aromatic 4-, 5-, 6- or 7-membered heterocycle; a saturated, partially or totally unsaturated or aromatic 3-, 4-, 5-, 6- or 7-membered carbocycle fused with a saturated, partially or totally unsaturated or aromatic 3-, 4-, 5-, 6- or 7-membered carbocycle; a saturated, partially or totally unsaturated or aromatic 3-, 4-, 5-, 6- or 7-membered carbocycle fused with a saturated, partially or totally unsaturated or aromatic 4-, 5-, 6- or 7-membered heterocycle; a saturated, partially or totally unsaturated or aromatic 4-, 5-, 6- or 7-membered heterocycle fused with a saturated, partially or totally unsaturated or aromatic 3-, 4-, 5-, 6- or 7-membered carbocycle; a saturated, partially or totally unsaturated or aromatic 4-, 5-, 6- or 7-membered heterocycle fused with a saturated, partially or totally unsaturated or aromatic 4-, 5-, 6- or 7-membered heterocycle; a C1-C8 alkyl-(saturated, partially or totally unsaturated or aromatic C3-C7 carbocycle); a C1-C8 alkenyl-(saturated, partially or totally unsaturated or aromatic C3-C7 carbocycle); a C1-C8 heteroalkyl-(saturated, partially or totally unsaturated or aromatic C3-C7 carbocycle); a C1-C8 alkyl-(saturated, partially or totally unsaturated or aromatic C4-C7 heterocycle); a C1-C8 heteroalkyl-(saturated, partially or totally unsaturated or aromatic C4-C7 heterocycle); a bicyclo[2.2.1]heptane; a bicyclo[2.2.1]heptene; a bicyclo[2.2.2]octane; or a bicyclo[2.2.2]octene;R3, non-substituted or substituted by at least one T2, represents an aryl; an aryl fused with a saturated, partially or totally unsaturated or aromatic 3-, 4-, 5-, 6- or 7-membered carbocycle; an aryl fused with a saturated, partially or totally unsaturated or aromatic 4-, 5-, 6- or 7-membered heterocycle; a heteroaryl; a heteroaryl fused with a saturated, partially or totally unsaturated or aromatic 3-, 4-, 5-, 6- or 7-membered carbocycle; a heteroaryl fused with a saturated, partially or totally unsaturated or aromatic 4-, 5-, 6- or 7-membered heterocycle; or an aryl fused with a saturated, partially or totally unsaturated or aromatic 4-, 5-, 6- or 7-membered heterocycle and further fused with a saturated, partially or totally unsaturated or aromatic 4-, 5-, 6- or 7-membered heterocycle; a C5-C7 cycloalkenyl; a C5-C7 cycloalkenyl fused with a saturated, partially or totally unsaturated or aromatic 4-, 5-, 6- or 7-membered heterocycle; or a saturated, partially or totally unsaturated or aromatic 4-, 5-, 6- or 7-membered heterocycle;R4, substituted or non-substituted by at least one T5, represents a linear or branched C2-C6 alkyl; a linear or branched C1-C6 fluoroalkyl; or a C3-C6 cycloalkyl;T1 independently represents a hydrogen atom, a halogen atom; an alkyl; —OH; —(X)x—C1-C6 alkyl; a linear or branched fluoroalkyl; a linear or branched —O—C1-C3 fluoroalkyl; —(X)x—C3-C6 cycloalkyl; —(X)x—(CT5T6)y-C3-C6 cycloalkyl; —(X)x—(CT5T6)y-aryl; —(X)x—(CT5T6)yCN; —(X)x—(CT5T6)yOT3; —(X)x—(CT5T6)yST3; —(X)—(CT5T6)yS(O)T3; —(X)x—(CT5T6)yS(O)2T3; —(X)x—(CT5T6)yNT3T4; —(X)x—(CT5T6)yC(O)T3; —(X)x—(CT5T6)yC(O)OT3; —(X)x—(CT5T6)yC(O)NT3T4; —(X)x—(CT5T6)yNT3C(O)NT3T4; —(X)x—(CT5T6)yNT3C(O)T4; —(X)x—(CT5T6)yNT3C(O)OT4; —(X)x—(CT5T6)yOC(O)NT3T4; —(X)x—(CT5T6)y S(O)2NT3T4 or (X)x—(CT5T6)yNT3S(O)2T4;T2 independently represents a hydrogen atom; a halogen atom; a linear or branched —O—C1-C3 alkyl; a linear or branched C1-C3 fluoroalkyl; a linear or branched O—C1-C3 fluoroalkyl; a linear or branched C1-C3 alkyl; or —CN; optionally two geminal T2 form with the carbon atom to which they are bonded, a C3-C7 cycloalkyl;X independently represents an oxygen atom; a sulphur atom; NT3; S═O or S(O)2;T3 and T4, identical or different, independently represent a hydrogen atom; a branched or linear C1-C6 alkyl; or a C3-C6 cycloalkyl; optionally T3, T4 and the nitrogen atom to which they are bonded form a C4-C6 heterocycloalkyl;T5 and T6, identical or different, independently represent a hydrogen atom; a fluorine atom; a linear or branched C1-C3 alkyl; or a C3-C6 cycloalkyl; optionally T5, T6 and the carbon atom to which they are bonded form a cyclopropyl;x independently represents 0 or 1;y independently represents 0, 1, 2 or 3; and a racemate, enantiomer, tautomer, atropisomer, diastereoisomer or a pharmaceutically acceptable salt thereof.
地址 Paris FR